2024-09-24-世界卫生组织-Utilizing_data_on_antimicrobial_use_and_knowledge_to_inform_regulatory_changes_to_antibiotic_packaging_and_support_antimicrobial_stewardship_efforts_in_Bangladesh_3页_136kb

Bangladesh has intensified efforts to combat antimicrobial resistance (AMR) through a national action plan and stewardship initiatives, but faces challenges from high antibiotic misuse due to over-the-counter sales and low public awareness. Data shows a significant increase in antibiotic use, with concerns over broad-spectrum antibiotics like cephalosporins. To address this, the Directorate General of Drug Administration (DGDA) launched a packaging initiative in 2022, requiring red markings and a "do not take without prescription" message on all antibiotics, following a baseline survey that highlighted poor retailer knowledge. By January 2024, nearly 80% of pharmaceutical companies had complied, supported by new regulations in the Drug and Cosmetics Act with penalties for non-compliance. The initiative aims to enhance awareness and reduce self-medication, with ongoing monitoring to assess impact and mitigate unintended consequences.